In this paper, we introduce a novel biosensor leveraging an InSb-source-based heterojunctionless nanowire TFET design tailored for biosensing applications. The incorporation of a low-bandgap InSb source enhances both drain current and sensitivity in our proposed biosensor. The unique feature of a hetero-but junctionless configuration eliminates the need for a physical metallurgical junction, presenting a fabrication process that is not only cost-effective but also streamlined, avoiding high thermal budgets and also eliminating the issue of random dopant fluctuations (RDF). Furthermore, unlike conventional homojunction-based TFET biosensors, where increased biomolecule permittivity reduces threshold voltage while elevating drain current, our proposed biosensor, featuring a III-V nanowire design, demonstrates intriguing behavior. With rising k-values, the ON current increases; however, concurrently, the threshold voltage also rises compared to conventional TFET biosensors. This unique behavior results in a simultaneous enhancement of ON current and reduction in OFF current, attributed to the increased threshold voltage. Consequently, the I <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ON</inf> /I <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">OFF</inf> ratio and sensitivity experience improvements, presenting promising outcomes for the proposed biosensor.
No takes yet. Share an insight, caveat, or question.
Anam et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: